• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Salivary Level as a Biomarker for Oral Squamous Cell Carcinoma.唾液水平作为口腔鳞状细胞癌的生物标志物
Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):103-112. doi: 10.21873/cgp.20245.
2
Salivary Levels as a Biomarker of Oral Squamous Cell Carcinoma.唾液水平作为口腔鳞状细胞癌的生物标志物。
Anticancer Res. 2021 Feb;41(2):765-772. doi: 10.21873/anticanres.14828.
3
Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.唾液基质金属蛋白酶-9作为口腔潜在恶性疾病和口腔鳞状细胞癌诊断的生物标志物。
Asian Pac J Cancer Prev. 2020 Jan 1;21(1):233-238. doi: 10.31557/APJCP.2020.21.1.233.
4
Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.唾液肿瘤坏死因子-α作为口腔白斑和口腔鳞状细胞癌的生物标志物
Asian Pac J Cancer Prev. 2019 Jul 1;20(7):2087-2093. doi: 10.31557/APJCP.2019.20.7.2087.
5
Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.基于非靶向和靶向定量蛋白质组学方法鉴定唾液生物标志物用于口腔癌检测。
Mol Cell Proteomics. 2019 Sep;18(9):1796-1806. doi: 10.1074/mcp.RA119.001530. Epub 2019 Jun 28.
6
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.唾液外泌体 miR-24-3p 可作为口腔鳞状细胞癌筛查的潜在检测生物标志物。
Biomed Pharmacother. 2020 Jan;121:109553. doi: 10.1016/j.biopha.2019.109553. Epub 2019 Nov 5.
7
Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.唾液中miRNA-184和miRNA-21在口腔鳞状细胞癌及口腔潜在恶性疾病中的诊断意义评估
Head Neck Pathol. 2023 Dec;17(4):961-968. doi: 10.1007/s12105-023-01600-7. Epub 2023 Nov 28.
8
Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.唾液蛋白质组分析揭示了用于检测口腔鳞状细胞癌的潜在唾液生物标志物。
Proteomics. 2015 Oct;15(19):3394-404. doi: 10.1002/pmic.201500157. Epub 2015 Aug 20.
9
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.全基因组唾液 microRNA 研究鉴定 miR-423-5p 作为口腔鳞状细胞癌有前途的诊断和预后生物标志物。
Theranostics. 2021 Jan 1;11(6):2987-2999. doi: 10.7150/thno.45157. eCollection 2021.
10
Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.口腔健康可能会影响基于mRNA的口腔鳞状细胞癌唾液生物标志物的性能。
Pathol Oncol Res. 2018 Oct;24(4):833-842. doi: 10.1007/s12253-017-0296-1. Epub 2017 Aug 31.

引用本文的文献

1
Identification of Non-Invasive Diagnostic Markers for Oral Squamous Cell Carcinoma Through Salivary Microbiome and Gene Expression Analysis.通过唾液微生物组和基因表达分析鉴定口腔鳞状细胞癌的非侵入性诊断标志物
Int J Mol Sci. 2025 Aug 21;26(16):8104. doi: 10.3390/ijms26168104.
2
Reference gene evaluation for normalization of gene expression studies with lymph tissue and node‑derived stromal cells of patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者淋巴组织和淋巴结衍生基质细胞基因表达研究标准化的参考基因评估
Oncol Lett. 2024 Sep 6;28(5):540. doi: 10.3892/ol.2024.14673. eCollection 2024 Nov.
3
Microbiota of Saliva: A Non-invasive Diagnostic Tool.唾液微生物群:一种非侵入性诊断工具。
Indian J Microbiol. 2024 Jun;64(2):328-342. doi: 10.1007/s12088-024-01219-4. Epub 2024 Mar 4.
4
Diversity and compositional differences in the oral microbiome of oral squamous cell carcinoma patients and healthy controls: a scoping review.口腔鳞状细胞癌患者与健康对照者口腔微生物群的多样性和组成差异:一项范围综述
Front Oral Health. 2024 Jun 11;5:1366153. doi: 10.3389/froh.2024.1366153. eCollection 2024.
5
Oral Squamous Cell Carcinoma: Focus on Biomarkers for Screening.口腔鳞状细胞癌:聚焦于筛查生物标志物
J Dent (Shiraz). 2024 Mar 1;25(1):1-16. doi: 10.30476/dentjods.2023.96159.1924. eCollection 2024 Mar.
6
The chemokine CCL20 can assist AFP in serological diagnosis of hepatocellular carcinoma.趋化因子CCL20可辅助甲胎蛋白进行肝细胞癌的血清学诊断。
Heliyon. 2024 Feb 21;10(5):e26774. doi: 10.1016/j.heliyon.2024.e26774. eCollection 2024 Mar 15.
7
OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus.OPLAH 蛋白表达可对食管鳞癌患者的预后进行分层。
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):343-353. doi: 10.21873/cgp.20386.
8
Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.基于生物信息学构建和验证口腔鳞状细胞癌代谢相关基因预后模型。
BMC Med Genomics. 2022 Dec 24;15(1):269. doi: 10.1186/s12920-022-01417-3.
9
FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.FCGBP 是一种有前途的预后生物标志物,并与口腔鳞状细胞癌的免疫治疗疗效相关。
J Immunol Res. 2022 Jun 12;2022:8443392. doi: 10.1155/2022/8443392. eCollection 2022.
10
Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.微生物定植与炎症可能是口腔鳞状细胞癌治疗效果不佳的原因
Front Oral Health. 2021 Oct 4;2:739499. doi: 10.3389/froh.2021.739499. eCollection 2021.

本文引用的文献

1
Salivary and Levels as Biomarkers for Oral Squamous Cell Carcinoma Diagnosis.唾液和水平作为口腔鳞状细胞癌诊断的生物标志物。
In Vivo. 2020 Sep-Oct;34(5):2353-2361. doi: 10.21873/invivo.12048.
2
How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches.如何计算我们的微生物?不同定量微生物组分析方法的效果。
Front Cell Infect Microbiol. 2020 Aug 7;10:403. doi: 10.3389/fcimb.2020.00403. eCollection 2020.
3
Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.唾液微生物组失调和细胞因子通过炎症影响口腔鳞状细胞癌。
Arch Microbiol. 2021 Jan;203(1):137-152. doi: 10.1007/s00203-020-02011-w. Epub 2020 Aug 11.
4
Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer.免疫抑制增加与卵巢癌腹水增加和预后不良有关。
Anticancer Res. 2019 Nov;39(11):5953-5962. doi: 10.21873/anticanres.13800.
5
Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer.口腔微生物组特征在口腔癌诊断和预后中的作用。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819867354. doi: 10.1177/1533033819867354.
6
Changes in oral microbial profiles associated with oral squamous cell carcinoma vs leukoplakia.与口腔鳞状细胞癌和白斑相关的口腔微生物谱变化。
J Investig Clin Dent. 2019 Nov;10(4):e12445. doi: 10.1111/jicd.12445. Epub 2019 Jul 24.
7
GENT2: an updated gene expression database for normal and tumor tissues.GENT2:一个更新的正常组织和肿瘤组织基因表达数据库。
BMC Med Genomics. 2019 Jul 11;12(Suppl 5):101. doi: 10.1186/s12920-019-0514-7.
8
CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.CD2用于预防头颈部肿瘤患者口腔黏膜炎的多中心随机研究。
Anticancer Res. 2019 Apr;39(4):1935-1942. doi: 10.21873/anticanres.13303.
9
Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer.解析梭杆菌属与胃肠道癌症之间关联的研究进展。
J Gastroenterol. 2019 Jan;54(1):33-41. doi: 10.1007/s00535-018-1512-9. Epub 2018 Sep 22.
10
Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.唾液中蛋白质组生物标志物的发现和临床前验证及其用于口腔鳞状细胞癌的早期检测
Oral Dis. 2019 Jan;25(1):97-107. doi: 10.1111/odi.12971. Epub 2018 Sep 25.

唾液水平作为口腔鳞状细胞癌的生物标志物

Salivary Level as a Biomarker for Oral Squamous Cell Carcinoma.

作者信息

Ueda Sei, Goto Mitsuo, Hashimoto Kengo, Hasegawa Shogo, Imazawa Masahiko, Takahashi Marico, Oh-Iwa Ichiro, Shimozato Kazuo, Nagao Toru, Nomoto Shuji

机构信息

Department of Maxillofacial Surgery, School of Dentistry, Aichi-gakuin University Graduate School of Medicine, Nagoya, Japan.

Department of Surgery, School of Dentistry, Aichi-gakuin University Graduate School of Medicine, Nagoya, Japan.

出版信息

Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):103-112. doi: 10.21873/cgp.20245.

DOI:10.21873/cgp.20245
PMID:33608307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7943213/
Abstract

BACKGROUND/AIM: This study investigated the utility of C-C motif chemokine ligand 20 (CCL20) expression in saliva as a biomarker for oral squamous cell carcinoma (OSCC) and also examined the associated microbiome.

MATERIALS AND METHODS

The study group included patients with OSCC or oral potentially malignant disorder (OPMD), and healthy volunteers (HVs). microarray and qRT-PCR were used to compare salivary CCL20 expression levels among groups. Data on CCL20 levels in oral cancer tissues and normal tissues were retrieved from a public database and examined. Furthermore, next-generation sequencing was used to investigate the salivary microbiome.

RESULTS

A significant increase in the expression level of CCL20 was observed in both OSCC tissues and saliva from patients with oral cancer. Fusobacterium was identified as the predominant bacteria in OSCC and correlated with CCL20 expression level. OSCC screening based on salivary CCL20 expression enabled successful differentiation between patients with OSCC and HVs.

CONCLUSION

CCL20 expression may be a useful biomarker for OSCC.

摘要

背景/目的:本研究调查了唾液中C-C基序趋化因子配体20(CCL20)表达作为口腔鳞状细胞癌(OSCC)生物标志物的效用,并研究了相关微生物群。

材料与方法

研究组包括OSCC患者、口腔潜在恶性疾病(OPMD)患者和健康志愿者(HV)。采用微阵列和qRT-PCR比较各组唾液中CCL20的表达水平。从公共数据库中检索并分析口腔癌组织和正常组织中CCL20水平的数据。此外,采用二代测序技术研究唾液微生物群。

结果

在OSCC组织和口腔癌患者的唾液中均观察到CCL20表达水平显著升高。梭杆菌被确定为OSCC中的主要细菌,且与CCL20表达水平相关。基于唾液CCL20表达的OSCC筛查能够成功区分OSCC患者和HV。

结论

CCL20表达可能是OSCC的一个有用生物标志物。